These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21404039)

  • 1. Pharmacokinetics and behavioral effects of liposomal hydromorphone suitable for perioperative use in rhesus macaques.
    Krugner-Higby L; KuKanich B; Schmidt B; Heath TD; Brown C
    Psychopharmacology (Berl); 2011 Aug; 216(4):511-23. PubMed ID: 21404039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental pharmacodynamics and analgesic efficacy of liposome-encapsulated hydromorphone in dogs.
    Krugner-Higby L; Smith L; Schmidt B; Wunsch L; Smetana A; Brown C; Heath TD
    J Am Anim Hosp Assoc; 2011; 47(3):185-95. PubMed ID: 21498589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and behavioral effects of an extended-release, liposome-encapsulated preparation of oxymorphone in rhesus macaques.
    Krugner-Higby L; KuKanich B; Schmidt B; Heath TD; Brown C; Smith LJ
    J Pharmacol Exp Ther; 2009 Jul; 330(1):135-41. PubMed ID: 19351868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of hydromorphone after intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta).
    Kelly KR; Pypendop BH; Christe KL
    J Am Assoc Lab Anim Sci; 2014 Sep; 53(5):512-6. PubMed ID: 25255074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs.
    Smith LJ; KuKanich B; Hogan BK; Brown C; Heath TD; Krugner-Higby LA
    J Vet Pharmacol Ther; 2008 Oct; 31(5):415-22. PubMed ID: 19000260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of hydromorphone hydrochloride in healthy horses.
    Martins FC; Keating SC; Clark-Price SC; Schaeffer DJ; Lascola KM; DiMaio Knych H
    Vet Anaesth Analg; 2020 Jul; 47(4):509-517. PubMed ID: 32409257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration of a single dose to American kestrels (Falco sparverius).
    Guzman DS; KuKanich B; Drazenovich TL; Olsen GH; Paul-Murphy JR
    Am J Vet Res; 2014 Jun; 75(6):527-31. PubMed ID: 24866507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers.
    Coda BA; Rudy AC; Archer SM; Wermeling DP
    Anesth Analg; 2003 Jul; 97(1):117-23, table of contents. PubMed ID: 12818953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of orally administered sustained- release hydromorphone in humans.
    Angst MS; Drover DR; Lötsch J; Ramaswamy B; Naidu S; Wada DR; Stanski DR
    Anesthesiology; 2001 Jan; 94(1):63-73. PubMed ID: 11135723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative Analgesia Provided by Liposomal Hydromorphone in Client-Owned Dogs Undergoing Limb Amputation.
    Krugner-Higby L; Smith LJ; Schmidt B; Steagall PV; Brown C; Heath TD
    J Am Anim Hosp Assoc; 2016; 52(1):13-21. PubMed ID: 26606204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of hydromorphone after intravenous and intramuscular administration in horses.
    Reed RA; Knych HK; Barletta M; Sakai DM; Ruch MM; Smyth CA; Ryan CA
    Vet Anaesth Analg; 2020 Mar; 47(2):210-218. PubMed ID: 31959534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydromorphone efficacy and treatment protocol impact on tolerance and mu-opioid receptor regulation.
    Kumar P; Sunkaraneni S; Sirohi S; Dighe SV; Walker EA; Yoburn BC
    Eur J Pharmacol; 2008 Nov; 597(1-3):39-45. PubMed ID: 18789923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiple-dose phase I study of intranasal hydromorphone hydrochloride in healthy volunteers.
    Rudy AC; Coda BA; Archer SM; Wermeling DP
    Anesth Analg; 2004 Nov; 99(5):1379-1386. PubMed ID: 15502034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral hydromorphone extended-release.
    Guay DR
    Consult Pharm; 2010 Dec; 25(12):816-28. PubMed ID: 21172762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology and pharmacokinetics of once-daily hydromorphone hydrochloride extended-release capsules.
    Vashi V; Harris S; El-Tahtawy A; Wu D; Cipriano A
    J Clin Pharmacol; 2005 May; 45(5):547-54. PubMed ID: 15831778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2008 Aug; 31(4):334-43. PubMed ID: 18638294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder.
    Nasser AF; Greenwald MK; Vince B; Fudala PJ; Twumasi-Ankrah P; Liu Y; Jones JP; Heidbreder C
    J Clin Psychopharmacol; 2016 Feb; 36(1):18-26. PubMed ID: 26650971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of hydromorphone HCl and a novel extended release hydromorphone on arterial blood gas values in conscious healthy dogs.
    Wunsch LA; Schmidt BK; Krugner-Higby LA; Smith LJ
    Res Vet Sci; 2010 Feb; 88(1):154-8. PubMed ID: 19692102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol.
    Sathyan G; Sivakumar K; Thipphawong J
    Curr Med Res Opin; 2008 Jan; 24(1):297-305. PubMed ID: 18062845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose proportionality and pharmacokinetics of extended-release (OROS®) hydromorphone: a phase 1, open-label, randomized, crossover study in healthy Taiwanese subjects.
    Vandenbossche J; Richards HM; Lu CC; Richarz U
    Int J Clin Pharmacol Ther; 2014 Mar; 52(3):217-26. PubMed ID: 24472398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.